By |

Profile

Celyad Oncology is a biopharmaceutical company, specialized in cell therapy. It develops technologies and treatments to treat severe diseases with poor prognosis. The company focuses on Immuno oncology, Cardiology, and Medical devices. Its main product candidates include CAR-T and C-Cure. The firm has CYAD-01 and CYAD-02 programs in pipeline. The company owns trademarks and service marks including CELYAD, C-CATH, C_CURE, CATH and C-CATHez and CARDIO 3 BIOSCIENCES. The firm has Cardiology and Immuno-oncology operating segments.

Contact Information

Website: www.celyad.com
Email: investors@celyad.com
Main Phone: +32 10394100
Address: Rue Edouard Belin 2
Address 2: Axis Business Park
City / Town: Mont-Saint-Guibert
Country: BE
Postal Code: 1435

Issuer Information

Exchange: NSD
CEO: Filippo Petti
Employees: 107

Equities News

Profile

Celyad Oncology is a biopharmaceutical company, specialized in cell therapy. It develops technologies and treatments to treat severe diseases with poor prognosis. The company focuses on Immuno oncology, Cardiology, and Medical devices. Its main product candidates include CAR-T and C-Cure. The firm has CYAD-01 and CYAD-02 programs in pipeline. The company owns trademarks and service marks including CELYAD, C-CATH, C_CURE, CATH and C-CATHez and CARDIO 3 BIOSCIENCES. The firm has Cardiology and Immuno-oncology operating segments.

Contact Information

Website: www.celyad.com
Email: investors@celyad.com
Main Phone: +32 10394100
Address: Rue Edouard Belin 2
Address 2: Axis Business Park
City / Town: Mont-Saint-Guibert
Country: BE
Postal Code: 1435

Issuer Information

Exchange: NSD
CEO: Filippo Petti
Employees: 107

Equities News

$ 7.13 $ -0.36 (-4.81%)
Last Price 7.13 Change $ -0.36 Change % -4.81 Tick N/A
Bid N/A Bid Size 0.00 Ask 10.38 Ask Size 300.00
Open 7.26 High 7.29 Low 7.13 Prev Close 7.49
Last Trade Volume 3,637 52 Wk Hi 13.02 52 Wk Low 4.10
Market Cap 99.4 mi Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 13,942,344.00 EPS (TTM) -3.86 PE Ratio N/A Exchange NSD
  Current 1 Week Ago 2 Weeks Ago 3 Weeks Ago
High Target Price Estimate 74 74 74 74
Low Target Price Estimate 49 74 74 49
Mean Target Price Estimate 61.5 74 74 61.5
Standard Deviation 17.68 0 0 17.68
Date of Most Recent Estimate 05/31/18 03/23/18 03/23/18 05/31/18
  Current 1 Month Ago 2 Months Ago 3 Months Ago
Strong Buy 3 1 1 1
Moderate Buy 0 0 0 0
Hold 0 0 0 0
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 1 1 1 1